| Literature DB >> 33506087 |
Anna Prunell-Castañé1,2, María Ángeles Jurado1,2,3, Isabel García-García1,2.
Abstract
INTRODUCTION: Binge eating disorder (BED) is a common psychiatric diagnosis characterized by the presence of episodes of loss of control over food consumption. Understanding the neurocognitive factors associated with binge eating pathology might help to design clinical strategies aimed at preventing or treating BED. However, results in the field are notably heterogeneous. In the current study, we aimed to establish whether binge eating behaviors (both at a clinical and at a non-clinical level) are associated with executive functions.Entities:
Keywords: BED, binge eating disorder; BMI, body mass index; Binge eating disorder; Eating disorders; Executive functions; Inhibitory control; Meta-analysis; Publication bias; Uncontrolled eating
Year: 2020 PMID: 33506087 PMCID: PMC7815657 DOI: 10.1016/j.abrep.2020.100337
Source DB: PubMed Journal: Addict Behav Rep ISSN: 2352-8532
Fig. 1Flowchart of the selection criteria for the present study.
Description of studies included in the first meta-analysis
| Study | BED n (females) | Controls n (females) | Pooled age | Pooled BMI | Evaluation of psychological comorbidities | Outcomes● | ||
|---|---|---|---|---|---|---|---|---|
| Scale▴ | Reported affective symptoms■ | Current psychiatric comorbidities | ||||||
| 45(45) | 45(45) | 28.1 | 27.7 | BDI-II | S-Diff in depression symptoms between groups. BDI score included as covariate. Depression negatively correlated with cognitive flexibility | _ | ||
| 32(18) | 126(60) | 43.22 | 25.38 | BDI-II | S-Diff in depression between groups. Results tested before and after covarying for depression (no differences found) | _ | ||
| 11(11) | 28(28) | 25.79 | 23.96 | DASS-21 | NS-Diff in depression between groups. Depression was not correlated with monetary temporal discounting task | BED group: psychotropic medication (n = 1) | ||
| 42(30) | 23(17) | 38.95 | 42.35 | PHQ-9 | S-Diff in depression symptoms between groups. No further control | _ | ||
| 18(12) | 18(15) | 45.1 | 38.54 | _ | _ | _ | ||
| 19(19( | 48(48) | 38.94 | 29.26 | IDS-SR | S-Diff in depression symptoms between groups. Depression as covariate had no effect on IGT performance | _ | ||
| 25(22) | 56(49) | 35.5 | 28.13 | BDI-II | None-to-mild depressive symptoms in BED group. Depressive symptoms were correlated with overall neuropsychological inefficiencies | BED group: psychiatric disorder not specified (n = 10) | ||
| 38(29) | 38(34) | 34.35 | 36.24 | _ | _ | Whole sample: specific phobia (12%), generalized anxiety disorder (10%), dysthymic disorder (6%), panic disorder (9%), agoraphobia (4%), social phobia (5%), alcohol abuse/dependence (3%), posttraumatic stress disorder (3%), premenstrual dysphoric disorder (2%), obsessive–compulsive disorder (2%), and others (1%) | ||
| 55(55) | 77(77) | 32.1 | 28.4 | _ | Presence of psychiatric disorders did not significantly correlate with performance on any executive function measures | BED group: mood disorder (n = 5), anxiety (n = 10) | ||
| 17(11) | 17(11) | 24.62 | 32.63 | HAM-D, | BED group reported subclinical levels of depression and anxiety. No further control | BED group: agoraphobia (n = 2), social phobia (n = 1), cannabis use disorder (n = 1), antisocial personality disorder (n = 1) | ||
| 22(18) | 44(36) | 14.99 | 85.66* | BDI-II | S-Diff in depression symptoms between groups. Affective symptoms were not correlated with neuropsychological test scores | _ | ||
| 48(37) | 96(65) | 38.76 | 36.32 | BDI-II | S-Diff in depression between groups. Depressive symptoms as covariate. Multivariate effect of depression was non-significant | Whole sample: major depressive disorder (n = 17), anxiety disorder (n = 24), posttraumatic stress disorder (n = 4), obsessive–compulsive disorder (n = 2) | ||
| 13(13) | 14(14) | 23.44 | 22.9 | BDI-II | S-Diff in depression and anxiety symptoms between groups. No further control | _ | ||
| 34(26) | 34(26) | 38.35 | 46.65 | PHQ-9 | S-Diff in depression between groups. Results tested before and after covarying for depression (no differences found) | _ | ||
| 21(17) | 21(16) | 24.56 | 21.79 | _ | _ | _ | ||
| 24(21) | 77(66) | 37.39 | 30.34 | PHQ-9, | S-Diff in depression between groups. No further control | Whole sample: depressive disorder (n = 16), anxiety disorder (n = 15), borderline personality disorder (n = 5), attention deficit hyperactivity disorder (n = 3), skin picking disorder (n = 1), substance abuse (n = 1) | ||
| 22(16) | 22(15) | 28.4 | 27.16 | _ | _ | _ | ||
| 70 (58) | 28(22) | 41.35 | 39.3 | DASS-21 | NS-Diff in depression. anxiety and stress symptoms between groups | _ | ||
| 24(24) | 80(80) | 25.45 | 25.6 | _ | _ | _ | ||
| 17(17) | 18(18) | 40.3 | 31.72 | BDI-II | S-Diff in depression symptoms between groups. No further control | BED group: 23.5% major depression, 17.6% panic disorder with agoraphobia, 11.8% social phobia, 5.9% post-traumatic stress disorder, 5.9% generalized anxiety disorder, 5.9% somatization disorder | ||
| 31(31) | 36(36) | 43.32 | 34.15 | BDI-II | S-Diff in depression symptoms between groups. Depression was not correlated with recent-probes task | BED group: affective and anxiety disorders were the most prevalent comorbidities ( | ||
| 31(31) | 29(29) | 42.88 | 34.03 | BDI-II | S-Diff in depression between groups. Depression was correlated with response time in all go trials | Whole sample: major depression (n = 2), dysthymia (n = 1), panic disorder (n = 2), social phobia (n = 2), specific phobia (n = 2), obsessive compulsive disorder (n = 1), post-traumatic stress disorder (n = 1), pain disorder (n = 1) | ||
| 54(49) | 74(72) | 36.63 | 31.46 | BDI-II | S-Diff in depression symptoms between groups. Results tested with and without BED patients on psychotropic medication (no differences found). Depression was not correlated with SSRT | BED group: psychotropic medication (n = 19) | ||
*BMI Percentile, **BMI z-score.
▴: DASS-21 = Depression, Anxiety and Stress Scales; BDI-II = Beck Depression Inventory-II; PHQ = Patient Health Questionnaire-Depression Scale; HAM-D = Hamilton Depression Rating Scale ; HAM-A = Hamilton Anxiety Rating Scale ; IDS-SR = Inventory for Depressive Symptomatology Self-Rated.
■ S-Diff = Significant differences; NS-Diff = Nonsignificant differences.
● BDS = Backward Digit Span; FDS = Forward Digit Span; WCST = Wisconsin Card Sorting Test; TMT = Trail Making Test; RCFT = Rey-Osterrieth Complex Figure Test; IGT = Iowa Gambling Task; DDT = Delay Discounting Task; BREIF-A = Behavior Rating Inventory of Executive Function-Adult version; SST = Stop Signal Task; CGT = Cambridge Gambling task; IED = Intra/Extradimensional Set-Shift Task; GNG = Go/No-Go task; HSCT = Hayling Sentence Completion Test; GDT = Game of Dice Task; DOT = Door Opening Task.
Fig. 2Effect size (Cohen’s d) and 95% confidence interval for the relationship between BED and executive functions.
Fig. 3Publication bias funnel plot of the first meta-analysis. Dots represent each study included.
Additional meta-analysis results
| N | Effect size | Heterogeneity | Publication Bias | |||||
|---|---|---|---|---|---|---|---|---|
| Studies | BED/Controls | d | P value* | I2 | Egger test | P value* | Trim-and-fill missing studies | |
| 12 | 472/685 | −0.17 | >0.9 | 72.86% | T = -0.73 | > 0.9 | 0 | |
| 12 | 432/589 | −0.21 | 0.11 | 40.23% | T = -0.69 | > 0.9 | 1 | |
*Bonferroni corrected.
Description of studies included in the second meta-analysis.
| Study | Experimental group | Control group | Pooled age | Pooled BMI | Evaluation of psychological comorbidities | Eating scale× | Outcomes● | ||
|---|---|---|---|---|---|---|---|---|---|
| Scale▴ | Reported affective symptoms■ | Current psychiatric comorbidities | |||||||
| 30(18) | 32(17) | 21.13 | 28.77 | _ | _ | TFEQ-R18 (uncontrolled eating) | |||
| 26(16) | 49(28) | 10.53 | 1.60** | _ | _ | _ | Child EDE (LOC eating frequency) | ||
| 50(50) | 66(66) | 19.15 | 23.86 | CES-D, | NS-Diff in depression and anxiety between groups. Results tested before and after covarying for depression and anxiety (no differences found) | _ | EDE-Q (total number of binge episodes) | ||
| 54(34) | 37(21) | 17.43 | 32.46 | _ | _ | _ | TFEQ (disinhibition factor) | ||
| 311(1 7 9) | _ | 15.7 | 65.58* | _ | _ | _ | DEBQ (emotional eating, external eating), QEWP-A, PFS | ||
| 37(29) | 33(25) | 40.26 | 47.10 | BDI-II, | S-Diff in depression and anxiety between groups. Depression and anxiety were correlated with BRIEF scores | _ | YFAS, BES | ||
| 47(27) | _ | 45.7 | 43.3 | BDI-II | Depression within the sample was relatively low. Depression as covariate | _ | EBPQ (emotional eating) | ||
| 33(33) | _ | 38.7 | 42.4 | _ | _ | _ | YFAS | ||
| 36(36) | _ | 30.6 | 21.3 | _ | _ | _ | YFAS | ||
| 48(32) | _ | 21.63 | 23.38 | _ | _ | _ | DEBQ (emotional eating, external eating) | ||
*BMI Percentile, **BMI z-score.
▴: BDI-II = Beck Depression Inventory-II; PHQ = Patient Health Questionnaire-Depression Scale, STAI = State-Trait Anxiety Inventory, SAI = State Anxiety Inventory, CES-D = Center for Epidemiological Studies Depression Scale.
■ S-Diff = Significant differences; NS-Diff = Nonsignificant differences.
TFEQ-R18 = Three-Factor Eating Questionnaire R-18; Child EDE = Child Eating Disorder Examination; EDE-Q = Eating Disorder Examination Self-report Questionnaire; DEBQ = Dutch Eating Behaviour Questionnaire; QEWP-A = Questionnaire of Eating and Weight Patterns, Adolescent version; PFS = Power of Food Scale; YFAS = Yale Food Addiction Scale; BES = Binge Eating Scale; EBPQ = Eating Behavior Patterns Questionnaire.
● WCST = Wisconsin Card Sorting Test; IGT = Iowa Gambling Task; BREIF = Behavior Rating Inventory of Executive Function; CPT-II = Conners Continuous Performance Test; TOL = Tower of London.
Fig. 4Correlation coefficients and 95% confidence intervals for the relationship between uncontrolled eating and executive functions.
Fig. 5Publication bias funnel plot of the second meta-analysis. Note that although in there are 10 dots, only 9 studies were included. That is because Steward et al. provided separated results for normal-weight and obese participants.